<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0975468D-C7A0-4AD1-99E9-AC18841FBAF3"><gtr:id>0975468D-C7A0-4AD1-99E9-AC18841FBAF3</gtr:id><gtr:name>Justus-Liebig University Giessen</gtr:name><gtr:address><gtr:line1>Justus-Liebig Universitat Giessen</gtr:line1><gtr:line2>Ludwigstrasse 23</gtr:line2><gtr:line4>Giessen</gtr:line4><gtr:postCode>D-35390</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BCD05341-5D48-43F1-A505-C169496883A1"><gtr:id>BCD05341-5D48-43F1-A505-C169496883A1</gtr:id><gtr:name>University of Hong Kong</gtr:name><gtr:address><gtr:line1>Pok Fu Lam Road</gtr:line1><gtr:line4>Hong Kong</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Hong Kong</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FBA10D69-BE5C-42A8-9DCF-4214809173FB"><gtr:id>FBA10D69-BE5C-42A8-9DCF-4214809173FB</gtr:id><gtr:name>London South Bank University</gtr:name><gtr:address><gtr:line1>103 Borough Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SE1 0AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31C8C3D6-0F45-4639-8C94-78C0C503AB52"><gtr:id>31C8C3D6-0F45-4639-8C94-78C0C503AB52</gtr:id><gtr:name>Genethon</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Pharmaceutical Sciences</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0975468D-C7A0-4AD1-99E9-AC18841FBAF3"><gtr:id>0975468D-C7A0-4AD1-99E9-AC18841FBAF3</gtr:id><gtr:name>Justus-Liebig University Giessen</gtr:name><gtr:address><gtr:line1>Justus-Liebig Universitat Giessen</gtr:line1><gtr:line2>Ludwigstrasse 23</gtr:line2><gtr:line4>Giessen</gtr:line4><gtr:postCode>D-35390</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BCD05341-5D48-43F1-A505-C169496883A1"><gtr:id>BCD05341-5D48-43F1-A505-C169496883A1</gtr:id><gtr:name>University of Hong Kong</gtr:name><gtr:address><gtr:line1>Pok Fu Lam Road</gtr:line1><gtr:line4>Hong Kong</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Hong Kong</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FBA10D69-BE5C-42A8-9DCF-4214809173FB"><gtr:id>FBA10D69-BE5C-42A8-9DCF-4214809173FB</gtr:id><gtr:name>London South Bank University</gtr:name><gtr:address><gtr:line1>103 Borough Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SE1 0AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31C8C3D6-0F45-4639-8C94-78C0C503AB52"><gtr:id>31C8C3D6-0F45-4639-8C94-78C0C503AB52</gtr:id><gtr:name>Genethon</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6A561D88-EDFB-4EB4-8388-A5F0D43A5E1F"><gtr:id>6A561D88-EDFB-4EB4-8388-A5F0D43A5E1F</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Mason</gtr:surname><gtr:orcidId>0000-0003-0411-602X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801072"><gtr:id>DCD63523-E1C3-43E4-B4DC-CC6E93FD0DE2</gtr:id><gtr:title>Understanding antimicrobial peptide mechanisms; a rationale for the improved design of antibiotics and vectors</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801072</gtr:grantReference><gtr:abstractText>The proposed research centres on understanding how natural and synthetic peptides interact with biological membranes as part of their mechanism of action. Understanding this process may be crucial to the development of new antibiotics, to fight bacteria such as MRSA and C. difficile or parasites such as Plasmodium falciparum (which causes malaria), and gene therapeutic vehicles to treat genetic diseases such as cystic fibrosis. Biological membranes surround human and bacterial cells and comprise a selective barrier between the cell and its environment and hence their properties and those of compounds that must cross or interact with these membranes are extremely interesting to researchers who seek to develop new classes of antibiotic or sophisticated new therapies. Peptide samples will be prepared either by using chemical synthesis techniques or by harnessing the machinery of bacteria. A combination of biophysical techniques in particular solid-state NMR spectroscopy, a powerful method for determining structural and dynamic features of both the peptides and the membrane that they interact with, and optical spectroscopy will be employed to understand exactly how the peptides behave in the membrane environment. When we understand what features of naturally occurring peptides are important to their function and how they can be manipulated, this information will be used to design peptides that may have more effective antibiotic activity or gene delivery function.</gtr:abstractText><gtr:technicalSummary>Due to the profound concerns over the unchecked rise in antibiotic resistance patterns seen globally, there is a recognised and urgent need to develop novel classes of antibacterial agents. Recent advances in understanding how naturally occurring antibiotic peptides function could lead to the production of novel, potent, synthetic antibiotic peptides with low toxicity. This study will test the hypothesis that with a more thorough understanding of the mechanism of antimicrobial action, in particular the interaction between the peptide and target membranes, rational design can produce antimicrobial peptides with enhanced potency. Research by Dr. Mason has already identified that a crucial determinant of antibacterial activity is the interaction between the peptide and the anionic lipid component of the bacterial plasma membrane and that the same membrane interactions underpin the activities of related peptides when disrupting the membranes of Plasmodium falciparum, the causative agent of malaria, and when delivering nucleic acids to human cells as part of gene therapeutic strategies. Therefore the impact of this project will be wide-reaching as, by re-examining the mechanism of antimicrobial peptide activity, using a combination of biophysical techniques and biological studies to obtain an improved mechanistic view of the critical membrane interactions, and linking this to vector peptides, we will develop new approaches to a range of problems from bacterial resistance and malaria to gene delivery.</gtr:technicalSummary><gtr:fund><gtr:end>2012-02-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>514312</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Justus Liebig University Giessen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Human Nutritional Biochemistry</gtr:department><gtr:description>Giessen</gtr:description><gtr:id>A4FCDE8B-FD30-4488-BB07-FC2A3E352A1E</gtr:id><gtr:impact>peptides have been produced and purified</gtr:impact><gtr:outcomeId>ZhdEGVQ6Ad4-1</gtr:outcomeId><gtr:partnerContribution>Prof. Dr Katja Becker's group will test our peptides for anti parasite activity. In particular this will include anti plasmodial assays but may include other eukaryotic parasites.</gtr:partnerContribution><gtr:piContribution>We are providing anti-malarial peptides for the team in a parasitology group in Giessen</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry</gtr:department><gtr:description>Edinburgh</gtr:description><gtr:id>B2C9321F-3862-4C44-BBCC-95B5035F6C70</gtr:id><gtr:impact>protein produced, manuscript in preparation</gtr:impact><gtr:outcomeId>AqF2ACBLsx2-1</gtr:outcomeId><gtr:partnerContribution>provision of an expression system for human beta defensin 2, an antimicrobial peptide</gtr:partnerContribution><gtr:piContribution>we will solve the membrane structure of this peptide and understand its mechanism of action</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Hong Kong</gtr:collaboratingOrganisation><gtr:country>Hong Kong, Special Administrative Region of China</gtr:country><gtr:department>Li Ka Shing School of Medicine</gtr:department><gtr:description>HK</gtr:description><gtr:id>646A1339-4FD4-41F3-91D3-0F408F075E34</gtr:id><gtr:impact>grant applications submitted to HK RGC</gtr:impact><gtr:outcomeId>Z4xLoMKg5Y7-1</gtr:outcomeId><gtr:partnerContribution>testing of novel nucleic acid delivery systems, anti-mycobacterial peptides and development of dry powder formulations for their delivery</gtr:partnerContribution><gtr:piContribution>provide peptides and project design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London South Bank University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>LSBU</gtr:description><gtr:id>968EFA08-1483-484B-852E-CEECE8BE9989</gtr:id><gtr:impact>Project grant at KCL funded by LSBU. Port-a-patch patch clamp equipment funded and acquired by KCL</gtr:impact><gtr:outcomeId>545a627b28fa82.17475999-1</gtr:outcomeId><gtr:partnerContribution>Financial and involvement in project planning</gtr:partnerContribution><gtr:piContribution>Project design and implementation. Access to facilities.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PHE</gtr:description><gtr:id>287F789B-4C99-4CD3-BA3D-807A2FAE0AAD</gtr:id><gtr:impact>None so far.</gtr:impact><gtr:outcomeId>58c1441038ed41.51511271-1</gtr:outcomeId><gtr:partnerContribution>Provision of antiseptic adapted strains of Pseudomonas aeruginosa.
Testing of antimicrobial peptides against a panel of PHE held isolates</gtr:partnerContribution><gtr:piContribution>Antimicrobial peptides for testing by PHE.
Biophysical and NMR metabolomic characterisation of antiseptic adapted Pseudomonas aeruginosa isolates</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genethon</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Genethon</gtr:description><gtr:id>07179167-1CBE-42E0-B6A6-56A13C65E8FC</gtr:id><gtr:impact>ChemBioChem paper from this year.</gtr:impact><gtr:outcomeId>bijxKZrY5Gs-1</gtr:outcomeId><gtr:partnerContribution>testing of nucleic acid vectors in cell culture</gtr:partnerContribution><gtr:piContribution>provide new nucleic acid delivery products</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC CASE studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>4798CF2B-F610-4B14-80DF-6910561F2C0D</gtr:id><gtr:outcomeId>mDrPMp95bps0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>102126</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC CASE Studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/L013576/1</gtr:fundingRef><gtr:id>0DA1AE4A-786E-445B-B0C1-2E1578CF7F50</gtr:id><gtr:outcomeId>545a5f52954de7.31148553</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>154833</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>London South Bank University</gtr:fundingOrg><gtr:id>F7206250-6880-45D0-815C-772D0B3E1E5F</gtr:id><gtr:outcomeId>545a6055abc606.74333629</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>195662</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Next generation facility users 4-year studentship EP/G068569/1 Molecular mechanisms of antimicrobial peptides: phase changes induced in endotoxic bacterial lipopolysaccharide.</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/G068569/1</gtr:fundingRef><gtr:id>FD46101D-A4B7-4424-8800-A65EE1E984AE</gtr:id><gtr:outcomeId>9127993E6F30</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We describe pH responsive peptides with enhanced nucleic acid transfer properties that outperform the commerically available state-of-the-art.</gtr:description><gtr:grantRef>G0801072</gtr:grantRef><gtr:id>4E7BD7ED-B7C7-4416-AD1F-C549520CA8CB</gtr:id><gtr:impact>We are sharing our materials with collaborators both at King's and in Mainz.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c1497e3abdb0.90282214</gtr:outcomeId><gtr:patentId>PCT/GB2014/051519</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Delivery peptides</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BA5F2DE8-E864-4EC0-A2AC-273FD050F822</gtr:id><gtr:title>Cationic amphipathic D-enantiomeric antimicrobial peptides with in vitro and ex vivo activity against drug-resistant Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8acdbd340400bc86f147347c47feedb0"><gtr:id>8acdbd340400bc86f147347c47feedb0</gtr:id><gtr:otherNames>Lan Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>545a5df4632e29.73082951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40E7F7E4-C02C-4452-BE1D-D53B98E2EF51</gtr:id><gtr:title>Structural contributions to the intracellular targeting strategies of antimicrobial peptides.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8acdbd340400bc86f147347c47feedb0"><gtr:id>8acdbd340400bc86f147347c47feedb0</gtr:id><gtr:otherNames>Lan Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>RfequdhLgUS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B124AB26-1C8A-4B79-BFAB-4D08BA77C3AF</gtr:id><gtr:title>Combined systems approaches reveal highly plastic responses to antimicrobial peptide challenge in Escherichia coli.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d2e345bd4e628020cd2400bdd8265db"><gtr:id>6d2e345bd4e628020cd2400bdd8265db</gtr:id><gtr:otherNames>Kozlowska J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_540e160e160d152ff</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADEE3786-CFA3-46B5-8ACE-A1786C9F0510</gtr:id><gtr:title>Antimicrobial Peptide Potency is Facilitated by Greater Conformational Flexibility when Binding to Gram-negative Bacterial Inner Membranes.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9142c68bf22e2bf701b45ce6d6f6ce3"><gtr:id>f9142c68bf22e2bf701b45ce6d6f6ce3</gtr:id><gtr:otherNames>Amos ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c14c21e6f3b6.98195965</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C9BB1E9-1A9B-4FA1-898B-5C361AEA7870</gtr:id><gtr:title>Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>ACS nano</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0892e62fdeb106d137a36d0686feb4b"><gtr:id>c0892e62fdeb106d137a36d0686feb4b</gtr:id><gtr:otherNames>Al-Ahmady ZS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1936-0851</gtr:issn><gtr:outcomeId>pm_12510_20_22857653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7926BDE-DD1C-45E7-AEDD-DE7B931ECB5F</gtr:id><gtr:title>Control of pH responsive peptide self-association during endocytosis is required for effective gene transfer.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8cd84b50577870a49212f820e631b5d"><gtr:id>a8cd84b50577870a49212f820e631b5d</gtr:id><gtr:otherNames>Iacobucci V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_12510_20_22226847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6348375-17C8-4957-9B43-AABB512057A7</gtr:id><gtr:title>NMR metabolomics of MTLn3E breast cancer cells identifies a role for CXCR4 in lipid and choline regulation.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/443d0141fec605b0dfdd555995f6cb5a"><gtr:id>443d0141fec605b0dfdd555995f6cb5a</gtr:id><gtr:otherNames>Vermeer LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>pm_12510_20_22432781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F016A35-C925-4C15-ADB3-0367AB6E45FF</gtr:id><gtr:title>A relationship betweengrowth behaviour and cystic fibrosis patient lung function identified in a metabolomic investigation.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d2e345bd4e628020cd2400bdd8265db"><gtr:id>6d2e345bd4e628020cd2400bdd8265db</gtr:id><gtr:otherNames>Kozlowska J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>doi_12510_013_0538_5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45E90988-D854-4027-9E02-7CCEB04D3412</gtr:id><gtr:title>Western blot evaluation of siRNA delivery by pH-responsive peptides.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c626ef33ea981aadb9c8541ee98610c8"><gtr:id>c626ef33ea981aadb9c8541ee98610c8</gtr:id><gtr:otherNames>Liang W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_12510_20_23436406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B9DF33A-287A-4F55-A052-4D3F6F7CC318</gtr:id><gtr:title>Incorporation of 2,3-diaminopropionic acid into linear cationic amphipathic peptides produces pH-sensitive vectors.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8acdbd340400bc86f147347c47feedb0"><gtr:id>8acdbd340400bc86f147347c47feedb0</gtr:id><gtr:otherNames>Lan Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>GcZA1rjGj8P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92D249B6-075E-4A48-B68E-E1882274D2AB</gtr:id><gtr:title>Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic a-helical peptides.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/443d0141fec605b0dfdd555995f6cb5a"><gtr:id>443d0141fec605b0dfdd555995f6cb5a</gtr:id><gtr:otherNames>Vermeer LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12510_20_22869378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E76B6ACA-5149-4298-8D24-AD8C1AB3E4EA</gtr:id><gtr:title>Manipulating the pH response of 2,3-diaminopropionic acid rich peptides to mediate highly effective gene silencing with low-toxicity.</gtr:title><gtr:parentPublicationTitle>Journal of controlled release : official journal of the Controlled Release Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efd2fa24e080eba9dd4b86e024824c70"><gtr:id>efd2fa24e080eba9dd4b86e024824c70</gtr:id><gtr:otherNames>Abbate V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0168-3659</gtr:issn><gtr:outcomeId>pm_540e160e160c53fef</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC579381-C1E8-4E61-B4D9-24E301A17D21</gtr:id><gtr:title>Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways.</gtr:title><gtr:parentPublicationTitle>Journal of controlled release : official journal of the Controlled Release Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f07589e6c9d7dc02d50b84b79e2fe3f8"><gtr:id>f07589e6c9d7dc02d50b84b79e2fe3f8</gtr:id><gtr:otherNames>Lam JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0168-3659</gtr:issn><gtr:outcomeId>pm_12510_20_22138072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F0A472F-54F5-4678-B648-9F639354D837</gtr:id><gtr:title>Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids.</gtr:title><gtr:parentPublicationTitle>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c626ef33ea981aadb9c8541ee98610c8"><gtr:id>c626ef33ea981aadb9c8541ee98610c8</gtr:id><gtr:otherNames>Liang W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0939-6411</gtr:issn><gtr:outcomeId>pm_12510_20_23702276</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801072</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>